Red biotechnology in Germany Viola Eckelt 73 JimengSun

73 JimengSun

1Potentielle Gefahren & Probleme73

with most of the leading laboratories worldwide being represented

in der der Frage nachgegangen

Red biotechnology in Germany Viola Eckelt 73 JimengSunStudienarbeit aus dem Jahr 2010 im Fachbereich BWL Sonstiges, Note: 1,9, Stuttgart Institute of Management and Technology, Veranstaltung: International Management, Sprache: Deutsch, Abstract: The entrance of biotechnology into medicine, especially driven by new genetic techniques, has led to promising new markets. Biotech companies are spending extraordinary sums in R&D before new technologies generate a return on the investment. In Germany alone